Dectrocel Healthcare And Research Profile
Key Indicators
- Authorised Capital ₹ 1.10 M
as on 16-11-2024
- Paid Up Capital ₹ 52.18 K
as on 16-11-2024
- Company Age 4 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -39.23%
(FY 2023)
- Profit -9219.01%
(FY 2023)
- Ebitda -2683.29%
(FY 2023)
- Net Worth 10403.95%
(FY 2023)
- Total Assets 9791.49%
(FY 2023)
About Dectrocel Healthcare And Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.10 M and a paid-up capital of Rs 52.18 K , as per Ministry of Corporate Affairs (MCA) records.
Saumya Shukla and Ankit Shukla serve as directors at the Company.
- CIN/LLPIN
U74999UP2020PTC132534
- Company No.
132534
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dectrocel Healthcare And Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saumya Shukla  | Director | 11-Aug-2020 | Current |
| Ankit Shukla | Director | 11-Aug-2020 | Current |
Financial Performance of Dectrocel Healthcare And Research.
Dectrocel Healthcare And Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.23% decrease. The company also saw a substantial fall in profitability, with a 9219.01% decrease in profit. The company's net worth Soared by an impressive increase of 10403.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dectrocel Healthcare And Research?
In 2023, Dectrocel Healthcare And Research had a public holding of 1.88%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vectrogen Healthcare Services Private LimitedActive 7 years 7 monthsSaumya Shukla and Ankit Shukla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dectrocel Healthcare And Research?
Dectrocel Healthcare And Research has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dectrocel Healthcare And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dectrocel Healthcare And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
